Despite suppressive combination antiretroviral therapy (ART), latent HIV-1 proviruses persist in patients. This latent reservoir is established within 48-72 h after infection, has a long half-life 1,2 , enables viral rebound when ART is interrupted, and is the major barrier to a cure for HIV-1 3 . Latent cells are exceedingly rare in blood (∼ 1 per 1 × 10 6 CD4 + T cells) and are typically enumerated by indirect means, such as viral outgrowth assays 4,5 . We report a new strategy to purify and characterize single reactivated latent cells from HIV-
reactivated, latently infected cells can be enriched on the basis of surface expression of HIV-1 Env protein.
To further purify the reactivated latent cells, we used flow cytometry to sort single cells from the magnetically enriched fraction on the basis of Env staining. Individual cells expressing both env and gag were identified by the combination of surface Env staining and single-cell HIV-1 gag mRNA expression. The frequency of gag mRNA-expressing single cells in patients with high IUPMs ranged from 10 to 50% of sorted cells (Supplementary Table 1 ). In individuals with relatively lower IUPMs (0.49-2.43), the percent of Env + Gag + single cells isolated varied from 0 to 4% (Supplementary Table 1 ).
We performed single-cell RNA sequencing (scRNA-seq) on Env + Gag + single cells captured through LURE and on control unfractionated single cells from the same PHA-activated culture obtained from donors 603, 605, and B207. In addition, we performed scRNA-seq on activated CD4 + T cells that were productively infected with HIV-1 YU2 (YU2) in vitro and purified through cell sorting using anti-Env antibodies ( Supplementary Fig. 2 ). Overall, 249 cells were characterized, of which 22 cells (8.8%) were removed by quality metrics 11 . Of the 227 cells retained, 33 were YU2-infected cells, 85 were cells captured with LURE, and 109 were unfractionated control cells from the same cultures ( Fig. 2a ). On average, we obtained ~1,500 expressed genes per cell ( Supplementary Fig. 3 ).
As expected, HIV reads were not detectable in the unfractionated, activated control cells (Fig. 2b) . In contrast, cells captured by LURE and YU2-infected cells showed similar percentages of total mRNA reads mapping to the HIV-1 genome (3.8 and 4.5%, respectively) 12 (Fig. 2b ). We conclude that reactivated latent cells captured by LURE contain RNA sequences mapping to the human genome and HIV-1 byscRNA-seq results.
We used Iterative Virus Assembler (IVA) software to reconstruct the virus from scRNA-seq reads in each individual CD4 + T cell 13 . HIV RNA recovered by scRNA-seq was dependent on proviral transcription, as determined by analysis of HIV-1 splice variants ( Supplementary Fig. 4a ). Fully reconstructed viruses were obtained from 26 cells infected with YU2 and from 19 cells captured by LURE ( Fig. 2c and Supplementary Fig. 4b ). All viruses obtained from 603 and 605 belonged to a single expanded viral clone (Fig. 2c) . We identified four different viruses in B207: two were fully reconstructed, and two others were partially reconstructed ( Fig. 2c ). All of the fully reconstructed viruses were completely intact when analyzed by Gene Cutter software. Thus, the combination of LURE and scRNA-seq can be used to recover full-length, intact HIV-1 from single reactivated latent cells. 
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To determine whether the full-length viruses expressed in the purified single cells obtained by LURE correspond to the intact latent viruses that emerge in viral outgrowth assays, we compared their env sequences ( Fig. 3a) . To do so, we performed quantitative and qualitative viral outgrowth assays (Q 2 VOAs) 14 and env singlegenome amplification (SGA) on DNA isolated from CD4 + T cells and compared these sequences to those found in the cells obtained from LURE.
Phylogenetic analysis of env sequences revealed that in donors 603 and B207, the env sequences obtained by LURE and Q 2 VOAs generally clustered together, were part of an expanded clone, and did not overlap significantly with sequences obtained by SGA of proviral DNA (Fig. 3a ). Participant 605 had an unusual distribution of SGA-obtained proviral DNA sequences in that there was a substantial overlap with the env sequences found in viral outgrowth cultures. Nevertheless, the majority of LURE-derived env sequences belong to the major viral outgrowth clone found in Q 2 VOAs (Fig. 3a ) in all three individuals. We conclude that the env sequences expressed by cells purified through LURE are typically identical to those found in viruses that emerge from latent cells in viral outgrowth cultures and therefore are replication competent.
Latent cells harboring identical replication-competent viruses may arise through T cell clonal expansion [14] [15] [16] [17] [18] [19] [20] [21] [22] or during a viral replicative burst when identical viruses infect a diverse group of T cells. To definitively distinguish between these possibilities, we analyzed the T cell receptor (TCR) sequences obtained from single latent cells captured by LURE. CD4 + T cells express unique antigen receptors produced by random TCR variable, diversity and joining gene segment (VDJ) recombination. T cells with identical TCRs are only produced by clonal expansion. As a control, we obtained TCR sequences from nearly 600 single CD4 + T cells from three healthy and three ART-treated, HIV-1-infected donors. We found that 99.9% of all control TCR sequences were unique, with only a single two-member clone identified in one of the six individuals ( Supplementary Fig. 5 ). In contrast, the TCR sequences derived from the latent cells with identical proviruses captured by LURE (Figs. 2c and 3a) were entirely clonal in all three donors ( Fig. 3b and Supplementary Fig. 6 ). The clonality was not due to T cell division in vitro, as there was no measurable T cell division in 36 h under our culture conditions ( Supplementary Fig. 7 ). Our data demonstrates that groups of latent cells containing identical replication-competent viruses are products of CD4 + T cell clonal expansion in vivo. 
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To further characterize the reactivated latent cells captured by LURE, we performed single-cell transcriptome analysis and compared the results to unfractionated, PHA-stimulated control cells from the same cultures and to activated CD4 + T cells productively infected with YU2. We performed hierarchical clustering through a principal-component analysis (PCA) called Seurat 23 using gene expression data from the 227 cells. This unbiased analysis identified three unique groups of genes that segregated the cells into three separate clusters. Each of these clusters was found to correspond to one of the three input groups: control, LURE, and YU2-infected cells ( Fig. 4a, Supplementary Fig. 8 , and Supplementary Table 2 ). Additional analysis that employed unsupervised clustering using all gene expression data (single-cell consensus clustering or SC3) confirmed these results from comparison of control cells and LUREsorted cells ( Supplementary Fig. 9 ). Thus, in PCA and unsupervised clustering, the reactivated latent cells captured by LURE cluster separately from uninfected (control) and actively infected CD4 + T cells.
To further understand the transcriptional differences between the three groups of cells, we identified differentially expressed genes (DEGs) (P < 0.01) between reactivated latent cells and PHAactivated control cells. Using unsupervised clustering, we grouped the cells on the basis of the expression of all significantly differentially expressed genes between LURE and control cell groups (P < 0.01, 778 genes) (Supplementary Table 3 ). Irrespective of donor, reactivated cells purified through LURE generally segregated from unfractionated, activated control cells in two of three individuals (Fig. 4b) , with cells from the third individual split between the LURE group and the control group. Similar results were also obtained through comparison with YU2-infected cells ( Supplementary  Fig. 10 ). We conclude that cells captured with LURE segregate from Gag + Env + Gag + Env + Ctrl Gag + Env + Ctrl Gag + Env + Ctrl Gag + Env + Fig. 4 | A distinct gene signature defines reactivated latent cells. a, Principal components analysis (PCA) clusters cells by group. The displayed output from Seurat t-Distributed Stochastic Neighbor Embedding (tSNE) for the three groups (control (black), Gag + Env + LURE (orange) and YU2 (gray)) is shown. Each data point represents a single cell. Seurat analysis identified three distinct clusters of genes, which define three groups of cells (circles (gene cluster 0), triangles (gene cluster 1), and squares (gene cluster 2)) by performing graph-based clustering over six principal components. All data obtained from individuals 603, 605, and B207 (control and LURE cells) and YU2-infected healthy donor cells (109 control cells, 85 LURE cells, and 33 YU2-infected cells) are shown. b, Heat map showing unsupervised clustering of differentially expressed genes between the Gag + Env + LURE-purified group (orange bars) and control unfractionated group (black bars). Cells from donor 603 are indicated in blue, 605 in green, and B207 in red along the top of the graph. Color in the heat map indicates the normalized level of expression. c, Graphs show expression of selected significantly differentially expressed genes in individual Gag + Env + LURE-purified and control unfractionated cells from participants 603 (blue), 605 (green), and B207 (red), as determined using MAST software. All data obtained from the participants (109 control cells and 85 LURE cells) are shown. Error bars show mean and s.d. Significant differential expression was determined using the likelihood ratio test embedded in the MAST software.
activated control cells and productively infected cells in three different methods of analysis.
Among the 240 genes that overlapped between the PCAidentified group and DEGs (P < 0.01), we found a number of genes highly expressed in the isolated LURE cells compared to controls that have been shown by independent analyses to be associated with HIV-1 latency (Fig. 4d ). For example, TIGIT 24, 25 and HLA-DR 26 were 140-and 76-fold upregulated, respectively, in cells purified by LURE compared to control cells, and CD32a 27 was not ( Fig. 4c and Supplementary Fig. 11 ). MiR-155, which inhibits TRIM32, prevents its interaction with HIV Tat and reinforces viral latency 28 , was 368 times more highly expressed in LURE cells compared to controls. Expression of chemokine CCL3, which is reported to have HIV-1-suppressive effects 29, 30 , was 795 times higher in LURE cells compared to controls. Finally, a number of transcription factors were among the top 15 differentially expressed genes, including the top differentially expressed gene, PRDM1 (1,365 × ). PRDM1 represses HIV-1 proviral transcription in memory CD4 + T cells by inhibition of HIV Tat 31 , and its overexpression is associated with lower levels of HIV-1 transcription in elite controllers 32 .
To further examine the differences between LURE and control cells, we performed enrichment analysis using the Gene Ontology database with the 240 genes that overlapped between the DEG and PCA analyses. Among the top ten most significantly enriched biological processes, eight were related to immune system function, suggesting that PHA-stimulated LURE and control cells differ in their expression of genes related to responses to pathogens. For example, LURE and control cells differ markedly in response to type I interferon and regulation of type I interferon production ( Supplementary Tables 4 and 5) , with control cells having higher expression of type I interferon responsive genes, such as IFIT3, ISG20, IRF1, IFI6, RSAD2, STAT1, XAF1, CTNNB1, and UBE2L6. Consequently, the control cells also show a higher overall expression of genes that are involved in response to viruses, such as CCL5, IFIT3, ISG20, IRF1, SERINC5, IL2RA, RSAD2, DDIT4, STAT1, and PIM2. Consistent with the altered gene expression program in reactivated latent cells, LURE and control cells show significant differences in the expression of genes that regulate transcription ( Supplementary Tables 4 and 5 ). For example, reactivated latent cells have higher levels of expression of transcriptional regulators PRDM1, MAF, IRF4, MTDH, IKZF3, and BATF3, whereas control cells have higher expression of PIM2, STAT1, HNRNPA2B, EZR, IRF1, CTNNB1, and NFKBIZ (Supplementary Tables 4 and 5). We conclude that reactivated latent cells differ from control cells in a number of ways, many of which are related to the suppression of cellular antiviral immunity.
Our analysis is limited to three individuals and to a single reactivation agent, PHA. Examination of additional individuals and methods of latent cell reactivation may reveal additional and/or different genes and pathways involved in maintaining latency. LURE purification of reactivated latent cells requires proviral activation to induce Env protein expression on the cell surface. Therefore, LURE captures a subset of latent cells with proviruses that can be reactivated in a single round of potent T cell stimulation 33, 34 . Owing to the relative resistance of some latent cells to reactivation 7 , LURE mirrors the viral outgrowth assay and is unable to capture the entirety of the latent reservoir. Furthermore, our analysis is limited to circulating CD4 + T cells that express Env on the cell surface that are recognized by our antibody cocktail. Finally, some reactivated latent cells are certainly lost during the multiple processing stages involved in the LURE protocol. Thus, the cells captured by LURE represent a fraction of the circulating latent reservoir that is closely related to and that overlaps with the latent cells that emerge in traditional viral outgrowth assays. Further experiments will be required to determine whether tissue-resident latent cells have a similar gene program upon reactivation.
T cell division in response to antigen or mitogens, like PHA and HIV-1 reactivation from latency, are stimulated by shared metabolic and transcriptional pathways, including NFκ B 35 . Once activated, productive HIV-1 infection typically leads to CD4 + T cell death by apoptosis or pyroptosis 36 . However, cell death after latency reactivation in vitro appears to be stochastic, with some cells being able to divide and survive after strong stimulation 19 . Our finding that latent cells can survive upon cell division in vivo confirms results from in vitro experiments 19 and is also consistent with the observation that the latent compartment contains groups of CD4 + T cells that harbor proviruses with identical env sequences 14, 19 . Purification of reactivated latent cells by LURE and subsequent TCR sequencing provides definitive evidence that these cells arise by clonal expansion in vivo. The data is consistent with the idea that the protracted longevity of the latent compartment is due at least in part to cell division [14] [15] [16] [17] [18] [19] [20] [21] [22] . Finally, because the reservoir is stable over time 1,2 , the finding that latent cells divide implies that they are also dying at a similar rate and that the reservoir is a dynamic compartment.
Antibody binding to Env-expressing cells in vivo leads to their accelerated clearance 37, 38 . Should latent cells undergoing clonal expansion in vivo also express viral proteins, they too could be targeted for clearance by HIV-1-specific cytotoxic T cells and natural killer (NK) cells or by antibody-dependent cellular cytotoxicity.
How does a subset of latent cells divide and still survive despite expression of HIV-1? Our single-cell transcriptomic analysis of purified primary CD4 + T cells demonstrates that reactivated latent cells can express a distinct transcriptional program that includes muted responses to type I interferon and factors such as MiR-155 and PRDM1 that can suppress HIV-1 transcription 28, 31, 32 . We speculate that active HIV-1 suppression during CD4 + T cell division could be one of the mechanisms maintaining the latent reservoir. Further studies will be required to determine whether interference with these cellular safeguards could contribute to accelerating latent HIV-1 clearance.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41591-018-0017-7.
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Methods Study subjects. All study participants were recruited by the Rockefeller University Hospital, New York, New York, USA. Written, informed consent was obtained from all subjects, all relevant ethical regulations were followed, and leukapheresis was performed according to protocols approved at the Rockefeller University by the Rockefeller Internal Review Board. PBMCs were isolated by Ficoll separation and frozen in aliquots. In all cases, HIV-1-infected individuals on therapy were confirmed to be aviremic at the time of sample collection.
Latency capture protocol. CD4 + T cells were isolated from ~1 × 10 9 PBMCs through negative selection using the Miltenyi CD4 + T cell isolation kit. Cells were cultured at 2 × 10 6 cells/ml in R10 (RPMI supplemented with 10% heatinactivated FCS, 10 mM HEPES, 100 U/ml penicillin-streptomycin) and 25% volume-conditioned medium. Conditioned medium was made by culturing healthy peripheral blood mononuclear cells (PBMCs) in R10 with PHA and IL-2 for 2 d; this was followed by a wash and 5 d in culture with IL-2 alone. The conditioned medium was then collected and frozen at -80 °C until use. 100 U/ml IL-2 (Peprotech), 1 µ g/ml PHA (Sigma), 10 µ M Z-VAD-FKM (R&D), 10 µ M ritonavir, 10 µ M dolutegravir, 10 µ M emtricitabine, 5 µ M tenofovir, and 10 µ M maraviroc (all Selleckchem) were added to the medium. 36 h later, cells were labeled with 5 µ g/ml each of biotinylated 3BNC117, 10-1074, and PG16, followed by Streptavidin PE (1:500, BD) and anti-PE magnetic beads (Miltenyi Biotech). Cells were then passed over a magnetic column, and bound cells were eluted for downstream analysis. For FACS sorting, cells were labeled with antibodies against the following proteins: gag bulk qPCR. RNA was extracted from equivalent numbers of cells irrespective of enrichment. gag qPCR was performed using RNA-to-Ct 1-step RT-PCR mix (ThermoFisher) and previously described primers 39 .
Single-cell sorting. All sorts were performed on BD FACS Aria into 96-well plates containing guanidine thiocyanate buffer (Qiagen) supplemented with 1% β -mercaptoethanol. Plates were immediately frozen on dry ice and transferred to long-term storage at -80 °C. LURE cells were gated on live, CD1c -CD8 -CD14 -CD20 -CD56 -CD3 + and were sorted based on Env staining. Control cells were gated on live, CD1c -CD8 -CD14 -CD20 -CD56and sorted CD3 + cells.
Single-cell gag qPCR and env PCR. Nucleic acids were isolated using SPRI bead cleanup, as described 40 . RNA was reverse-transcribed into cDNA using an oligo(dT) primer. gag qPCR was performed on one-fifth of the cDNA 39 . Gag + Env + cells were selected on the basis of the presence of cell-associated gag RNA measured by qPCR. Control cells were assayed for gag RNA, and none was detected. Nested env PCR was performed on one-fifth of the cDNA 14 .
SGA of env DNA and Q 2 VOAs. DNA was extracted from isolated CD4 + T cells as previously described 16 , and SGA of env DNA was performed as previously described 14 . Q 2 VOAs and downstream analysis were performed and processed as previously described 14 . For quality control, Q 2 VOAs were performed more than once and on samples taken at two different time-points for donor B207. IUPM calculations were performed using the data from all independent experiments using the calculator IUPMStats 41 .
Clustering env Sequences. env nucleotide sequences were translation-aligned using ClustalW 2.1 with the BLOSUM cost matrix in Geneious v10.0.3. A maximum-likelihood tree was then inferred using PhyML 3.1 under the GTR model with 1,000 bootstrap replicates.
YU2 infection and sorting. CD4 + T cells were activated and infected with YU2 and labeled as previously described 37 . CD4 lo Env + cells were sorted.
Single-cell RNA-seq. RNA-seq libraries were constructed based on Trombetta et al. 42 using primers from Islam et al. 43 Briefly, RNA was converted to full-length cDNA using oligo(dT) priming (Bio-5 ′ -AAT GATACGGCGACCACCGATCGTTTTTTTTTTTTTTTTTTTTTT TTTTTTTTT-3′ ) and SMART template switching technology (all RNA oligonucleotides: Bio-5′ -AAUGAUACGGCGACCACCGAUNNNNNGGG-3′ ) followed by 24 cycles of PCR preamplification of cDNA (primer: Bio-5′ -GAAT GATACGGCGACCACCGAT -3′ ). We used the amplified cDNA to construct standard Illumina sequencing libraries with the Nextera XT library preparation kit. Samples were sequenced by Illumina NextSeq.
RNA-seq analysis. The quality of the RNA-seq libraries was evaluated using the FastQC1 tool 44 . We used the STAR (2.4.1d) 45 aligner to map the raw paired-end reads to the reference genome GRCh37/hg19. The gene-level counts were obtained using HTSeq 44 . We performed a saturation analysis to detect the number of detected genes and filtered out the outlier cells, as described in Gaublomme et al. 11 .
Briefly, we excluded cells with a number of aligned reads < 25,000 and a percentage of identified genes that was < 20% of the group maximum. Normalized expression values were calculated using the scran package 46 in Bioconductor. Heat maps and dot plots were generated in R. The gene counts were used to infer the DEGs in the data by MAST (v1.2.1) [47] .
Analysis of HIV splice variants.
We recovered the reads that failed to map to the human genome and mapped these reads to annotated junctions between HIV splice donors and acceptors to reconstruct the splice variants present in the scRNAseq data.
HIV read alignment and reconstruction. We carried out HIV assembly analysis on the all reads that failed to map to the human genome by the IVA de novo assembler (v1.0.7) 13 .
T cell receptor identification. TraceR 48 was used to reconstruct full-length, paired TCR sequences. TCR sequences unable to be recovered from RNA-seq reads were amplified as previously described 49 .
PCA Seurat. We used the Seurat package (v1.4.0.16) to identify variable genes, principal components (PCs), clusters, and gene markers, as described 23 . Briefly, the software identifies highly variably expressed genes using a normalized z-score, performs linear dimensional reduction (PCA) on the filtered genes, obtains additional transcriptome PCA loading genes using projection of these principal components to the entire dataset, determines groups by clustering the t-SNE significant principal component scores on the basis of density, and performs discovery of gene markers. We also used the Improved Stochastic Ranking Evolution Strategy algorithm [50] , implemented by NLopt, to find the optimal set of PCs and parameters and to find the optimal set of clusters that best correlate with each group of cells.
Single-cell consensus clustering. The SC3 tool 51 (with default settings) was used for unsupervised clustering of single cells in this study. SC3 consistently integrates different clustering solutions through a consensus approach and identifies marker genes, which are highly expressed in only one of the clusters, and distinguishes these genes from the remaining ones 51 .
We have tested combinations of clustering settings (k = 2, 3, and 4) and used a quantitative measure of the diagonality of the consensus matrix to select the k (the number of clusters originally identified) in which the measure is closest to 1 (k = 3). We then used SC3 (area under the receiver operating characteristic curve (AUROC) > 0.6 and false-discovery rate (FDR) < 0.1) to identify marker genes that are highly expressed in only one of the clusters, which is distinguishable from all of the remaining clusters. 
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Experimental design 1. Sample size
Describe how sample size was determined.
Samples were chosen based on reproducibility of the LURE assay and availability of patient material. Sample size (cell number) was determined to be adequate based on the magnitude and consistency of measurable differences between groups.
Data exclusions
Describe any data exclusions.
Single-cell RNASeq libraries were excluded based on the number of mapped reads and number of identified genes. We introduced hard lower bounds for the cutoff values (number of aligned reads>25,000; percentage of identified transcripts>20%) and only retain cells that scored above the cutoff in both cases.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
Replicate experiments were successful. We optimized the LURE method and then tested its reproducibly on multiple individuals.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
No randomization was performed because we took unbiased approaches when analyzing the single cell data.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Investigators were not blinded to patient characteristics during experiments because blinding was not relevant to our study. The nature of these experiments included negative controls from the same samples, and LURE, by definition must be performed on HIV+ individuals. Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used. Describe the software used to analyze the data in this study.
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Flow cytometry data analyzed using FlowJo (v10). IUPMStats was used to calculate IUPM. Phylogenetic trees were made using ClustalW 2.1 with the BLOSUM cost matrix in Geneious v10.0.3 followed by PhyML 3.1 under the GTR model with 1000 bootstraps. RNASeq libraries were analyzed using fastQC1, STAR aligner, HTSEQ and differentially expressed genes analyzed by MAST. Virus assembly was performed using IVA de novo assembler. TCR sequences were recovered using TraceR. PCA was performed using Seurat software with NLopt. Unsupervised clustering was performed by Single-cell Consensus Clustering (SC3). Statistics were calculated in Prism software.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic. Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
ART treated patient information is included in the supplementary information. Patients were selected to be stably treated and virologically suppressed for at least one year. We did not exclude patients based on age or sex. Healthy donors tested negative for blood borne pathogens.
